DAVID GRAHAM to Follow-Up Studies
This is a "connection" page, showing publications DAVID GRAHAM has written about Follow-Up Studies.
Connection Strength
0.707
-
Autoimmune gastritis: long-term natural history in na?ve Helicobacter pylori-negative patients. Gut. 2023 01; 72(1):30-38.
Score: 0.098
-
Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol. 2018 Nov 07; 24(41):4698-4707.
Score: 0.076
-
Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol. 2018 Jan; 33(1):37-56.
Score: 0.072
-
Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010 May; 31(10):1104-11.
Score: 0.042
-
Failures in a proton pump inhibitor therapeutic substitution program: lessons learned. Dig Dis Sci. 2007 Oct; 52(10):2813-20.
Score: 0.034
-
Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004 Sep; 53(9):1235-43.
Score: 0.028
-
Risk of metastasis among patients diagnosed with high-risk T1 esophageal adenocarcinoma who underwent endoscopic follow-up. Dis Esophagus. 2024 Jul 31; 37(8).
Score: 0.028
-
Duodenal erosions after eradication of Helicobacter pylori infection. Gastrointest Endosc. 2001 Oct; 54(4):448-53.
Score: 0.023
-
Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol. 2001 Sep; 54(9):679-83.
Score: 0.023
-
Secondary prevention of gastric cancer: merging the endoscopic atrophic border with OLGA staging. Gut. 2020 06; 69(6):1151-1152.
Score: 0.020
-
A randomized comparison of dilatation alone versus dilatation plus laser in patients receiving chemotherapy and external beam radiation for esophageal carcinoma. Dig Dis Sci. 1998 Oct; 43(10):2255-60.
Score: 0.019
-
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut. 2019 01; 68(1):11-17.
Score: 0.018
-
An objective end point for dilation improves outcome of peptic esophageal strictures: a prospective randomized trial. Gastrointest Endosc. 1997 May; 45(5):354-9.
Score: 0.017
-
Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test. Am J Gastroenterol. 1996 Apr; 91(4):690-4.
Score: 0.016
-
Endoscopic retreatment after successful initial hemostasis prevents ulcer rebleeding: a prospective randomized trial. Endoscopy. 1996 Mar; 28(3):288-94.
Score: 0.016
-
Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry. Endoscopy. 2015 Nov; 47(11):980-7.
Score: 0.015
-
Prospective validation of the Baylor bleeding score for predicting the likelihood of rebleeding after endoscopic hemostasis of peptic ulcers. Gastrointest Endosc. 1995 Jun; 41(6):561-5.
Score: 0.015
-
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection. Aliment Pharmacol Ther. 1995 Apr; 9(2):209-12.
Score: 0.015
-
Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus. Gastrointest Endosc. 1995 Mar; 41(3):189-95.
Score: 0.015
-
Barrett's esophagus suspected at endoscopy but no specialized intestinal metaplasia on biopsy, what's next? Am J Gastroenterol. 2014 Feb; 109(2):178-82.
Score: 0.014
-
Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol. 1993 Nov; 28(11):939-42.
Score: 0.013
-
Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori. Scand J Gastroenterol. 1993 Oct; 28(10):924-8.
Score: 0.013
-
Biliary stenting in the management of large or multiple common bile duct stones. Gastrointest Endosc. 2010 Jun; 71(7):1200-1203.e2.
Score: 0.010
-
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. Am Heart J. 2009 Apr; 157(4):606-12.
Score: 0.010
-
Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesions. Scand J Gastroenterol. 2009; 44(11):1370-6.
Score: 0.010
-
Dramatic changes in the prevalence of Helicobacter pylori infection during childhood: a 10-year follow-up study in Russia. J Pediatr Gastroenterol Nutr. 2007 Oct; 45(4):428-32.
Score: 0.009
-
Clinical impact of stool cultures for Campylobacter in adults with acute or chronic diarrhea. South Med J. 1987 Jun; 80(6):709-11.
Score: 0.009
-
Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet. 2002 Mar 16; 359(9310):931-5.
Score: 0.006
-
Sustained increase in gastric antral epithelial cell proliferation despite cure of Helicobacter pylori infection. Am J Gastroenterol. 2000 Apr; 95(4):930-5.
Score: 0.005
-
Natural history of Helicobacter pylori infection in childhood: 12-year follow-up cohort study in a biracial community. Clin Infect Dis. 1999 Feb; 28(2):279-82.
Score: 0.005
-
Bougienage is effective therapy for most benign esophageal strictures. JAMA. 1978 Sep 01; 240(9):844-7.
Score: 0.005
-
Acquisition versus loss of Helicobacter pylori infection in Japan: results from an 8-year birth cohort study. J Infect Dis. 1998 Sep; 178(3):717-21.
Score: 0.005
-
Mast cell involvement in gastritis with or without Helicobacter pylori infection. Gastroenterology. 1997 Sep; 113(3):746-54.
Score: 0.004
-
Natural history of benign esophageal stricture treated by dilatation. Gastroenterology. 1983 Aug; 85(2):346-50.
Score: 0.002